Bayer

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Bayer and other ETFs, options, and stocks.

About BAYRY

Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health.

CEO

William N. Anderson

CEOWilliam N. Anderson

Employees

88,078

Employees88,078

Headquarters

Leverkusen, Nordrhein-Westfalen

HeadquartersLeverkusen, Nordrhein-Westfalen

Founded

1952

Founded1952

Employees

88,078

Employees88,078

BAYRY Key Statistics

Market cap

39.34B

Market cap39.34B

Price-Earnings ratio

-15.58

Price-Earnings ratio-15.58

Dividend yield

0.23%

Dividend yield0.23%

Average volume

1.98M

Average volume1.98M

High today

$10.05

High today$10.05

Low today

$9.84

Low today$9.84

Open price

$9.87

Open price$9.87

Volume

450.85K

Volume450.85K

52 Week high

$14.85

52 Week high$14.85

52 Week low

$7.03

52 Week low$7.03

BAYRY News

TipRanks 8h

Insider-Linked Investor Buys €1.69 Million in Bayer Shares

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

Benzinga 10h

Bayer Says 'Not Now' To Monsanto Spin-Off Amid Ongoing Roundup Legal Battle

Bayer AG (OTC:BAYRY) has ruled out a Monsanto spin-off for now despite facing mounting lawsuits tied to its Roundup weedkiller, a legal battle that continues to...

The Wall Street Journal 18h

Bayer’s AgTech Push in the Face of Uncertainty - WSJ

...

Analyst ratings

75%

of 20 ratings

Buy

75%

Hold

25%

Sell

More BAYRY News

Seeking Alpha 19h

Bayer says no plans to spin off Monsanto despite litigation threat

Bayer (BAYRY) (BAYZF) has no plans to spin off Monsanto, a company representative told Reuters on Tuesday, even as the company faces a flurry of lawsuits over i...

TipRanks 1d

Bayer announces new investigational data from Kerendia’s Phase III trial

Bayer (BAYRY) announced that new investigational data from Kerendia’s Phase III clinical trial program will be presented in scientific sessions at the 63rd Euro...

TipRanks 5d

Bayer assumed with a Hold at Jefferies

Jefferies analyst Michael Leuchten assumed coverage of Bayer (BAYRY) with a Hold rating and a price target of EUR 40, up from EUR 25. Litigation resolution rema...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.